Company intelligence
QPS Holdings, LLC
A global CRO supporting drug development across preclinical, bioanalysis, clinical trials & clinical research services.
About QPS Holdings, LLC
QPS is a GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, preclinical, and clinical drug development services. An award-winning leader focused on bioanalytics and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction and turnkey laboratories and facilities. We are passionate about our work, creating value for patients and customers while generating opportunities for employees to thrive. Since 1995, it has rapidly expanded from a tiny bioanalysis shop to a full-service CRO with 1100+ employees in the US, Europe, India and Asia. Today, it offers expanded pharmaceutical contract R&D services with special expertise in Neuropharmacology, DMPK, Toxicology, Bioanalysis, Translational Medicine, and Clinical Development. Through continual enhancements in capacities and resources, QPS stands tall in its commitment to deliver superior quality, skilled performance and trusted service to its valued customers.
Verified activity
Signals from QPS Holdings, LLC
5 published signals
Presence & Recognition
QPS Holdings, LLC is onsite at the NLS Days 2026 conference in Booth H:05 to discuss clinical trials, preclinical, and bioanalysis solutions.
Reported by QPS Holdings, LLC
Presence & Recognition
QPS Holdings, LLC will be attending Nordic Life Science Days in Stockholm at Booth H:05.
Reported by Edwin van Vulpen MBA
Research & Knowledge
QPS Holdings, LLC published a paper and insights regarding the limitations of quantitative PPB limits thanks to the IQ consortium.
Reported by Jenny Pedersen
Presence & Recognition
QPS Holdings, LLC is attending the OCTSoCal 2026 conference in San Diego.
Reported by QPS Holdings, LLC
Presence & Recognition
QPS Holdings, LLC is attending ISSX 2026 at booth 209 to discuss fast-tracking DMPK studies with Patrick McAnulty, Rachel Whisnant, and Renee Louis.
Reported by QPS Holdings, LLC